12:48 EDT Radiopharm (RADX) Theranostics trading halted, volatility trading pause
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RADX:
- Radiopharm Theranostics: Promising Pipeline and Strategic Advancements Drive Buy Rating
- Radiopharm Theranostics Limited: Promising Clinical Developments and Strategic Growth Potential Drive Buy Rating
- Radiopharm reports FY25 closing cash balance $29.12M
- Radiopharm receives IND approval from US FDA to initiate study of RV-01
- Radiopharm appoints Sartor to Scientific Advisory Board